Literature DB >> 2455220

Intravenous gamma-globulin therapy and serum IgG subclass levels in intractable childhood epilepsy.

A Plebani1, M Duse, S Tiberti, M A Avanzini, V Monafo, E Menegati, A G Ugazio, G R Burgio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2455220

Source DB:  PubMed          Journal:  Monogr Allergy        ISSN： 0077-0760


× No keyword cloud information.
  5 in total

Review 1.  Management of intractable epilepsy.

Authors:  J H Livingston
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

2.  High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome; an add-on study.

Authors:  B G van Engelen; W O Renier; C M Weemaes; P F Strengers; P J Bernsen; S L Notermans
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

Review 3.  The use of IVIG in neurological disease.

Authors:  A I Levinson
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

4.  Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo.

Authors:  Z D Ling; E Yeoh; B T Webb; K Farrell; J Doucette; D S Matheson
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

5.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.